Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,580.00
+3.70 (0.23%)
Jul 31, 2026, 3:30 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 909.21 billion as of July 31, 2026. Its market cap has increased by 35.19% in one year.
Market Cap
909.21B
Enterprise Value
883.68B
Revenue
336.53B
Ranking
n/a
PE Ratio
26.19
Stock Price
1,580.00
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 909.21B, an increase of 9,367.73%. That is a compound annual growth rate of 20.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 909.21B | 32.33% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.08T |
| Cipla | 1.19T |
| Zydus Lifesciences | 1.12T |
| Mankind Pharma | 1.02T |
| Laurus Labs | 980.49B |
| Alkem Laboratories | 695.45B |
| Glenmark Pharmaceuticals | 630.41B |
| Ipca Laboratories | 443.42B |